STOCK TITAN
  1. Home
  2. News
  3. MDT

Medtronic plc - MDT STOCK NEWS

Welcome to our dedicated page for Medtronic plc news (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic plc stock.

Medtronic plc (NYSE: MDT) is an American medical device company with its operational and executive headquarters in Minneapolis, Minnesota, and legal headquarters in Dublin, Ireland, following its acquisition of Covidien in 2015. As one of the largest medical-device companies globally, Medtronic specializes in developing and manufacturing therapeutic medical devices for chronic diseases.

The company’s extensive product portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. It markets these products to healthcare institutions and physicians worldwide, with international sales accounting for approximately 50% of its total revenue.

In a recent announcement on April 10, 2024, Medtronic unveiled significant advancements in artificial intelligence (AI) for endoscopic care through the launch of ColonPRO™ software for the GI Genius™ intelligent endoscopy system. This new software improves polyp detection and introduces procedural highlights to enhance physicians' workflow. The company has also entered into a collaboration with Modernizing Medicine® to integrate AI-driven data with electronic health records (EHR).

Medtronic recently reported its financial results for the fourth quarter and fiscal year 2024, showcasing a global revenue of $32.364 billion, a 3.6% increase compared to the previous year. The company's revenue growth was fueled by advancements in its Cardiovascular, Neuroscience, Medical Surgical, and Diabetes portfolios.

In addition to its financial performance, Medtronic has made strides in technological innovation. The U.S. FDA approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for chronic pain treatment, demonstrating the company’s commitment to addressing unmet clinical needs and improving patient care through advanced technologies.

Medtronic remains dedicated to its mission of alleviating pain, restoring health, and extending life, driven by a global team of over 95,000 employees across 150 countries. The company continues to leverage its diverse knowledge and insatiable curiosity to deliver innovative solutions that transform lives. For more information, visit Medtronic's official website.

News

Medtronic Named One of America's Most JUST Companies

Rhea-AI Summary
JUST Capital, in collaboration with CNBC, released its annual JUST 100 list, recognizing American corporate leadership on business issues prioritized by the public. Medtronic was named one of America's Most JUST Companies for the 2nd consecutive year, demonstrating commitment to serving workers, customers, communities, the environment, and shareholders. The JUST 100 companies outperform their peers financially and demonstrate better performance in areas such as paying a living wage, career development training, parental leave, water usage, CO2 emissions, renewable energy use, profit margin, return on equity, and dividend yield.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
-
News

Medtronic: Here Comes the Sun - 3 Things To Know About Our Solar Footprint

Rhea-AI Summary
Medtronic has been investing in renewable energy sources like solar, with a commitment to be net zero by 2045. The company's first solar farm opened in 2014 and they have since expanded their solar energy footprint globally, with the recent addition of a solar energy farm at their Mounds View, Minnesota campus. Medtronic used approximately 414,300 megawatt hours (MWh) of renewable electricity last year, accounting for more than 46% of their total electricity usage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
-
News

Medtronic LABS President Ruchika Singhal Named “Corporate Social Innovator of the Year” by Schwab Foundation

Rhea-AI Summary
Medtronic LABS president, Ruchika Singhal, was named the 2024 'Corporate Social Innovator of the Year' by the Schwab Foundation for Social Entrepreneurship. The independent nonprofit organization, supported by Medtronic, has impacted over 1.6 million patients, enrolled 237,000 people in healthcare programs, and improved over 100,000 lives through its data, technology, and partnerships to address health issues in underserved communities globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
News

FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Rhea-AI Summary
Medtronic plc (MDT) announces FDA approval of Percept™ RC Deep Brain Stimulation (DBS) system, the latest innovation in the Percept™ family, offering personalized treatment for patients with movement disorders and epilepsy. The system features BrainSense™ technology, SenSight™ directional leads, and a rechargeable neurostimulator with at least 15 years of service life and rapid recharging capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags
fda approval
-
News

Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor

Rhea-AI Summary
Medtronic plc (MDT) receives CE Mark approval for the MiniMed™ 780G system with Simplera Sync™ sensor, offering improved user experience and half the size of previous sensors. The system automatically adjusts glucose levels and features a Meal Detection™ feature to reduce post-meal hyperglycemia. The system is also compatible with the world's only 7-day infusion set and requires no fingersticks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags
none
-
News

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

Rhea-AI Summary
Medtronic plc (MDT) has received CE Mark for its Micra™ AV2 and Micra™ VR2, the next generation of its miniature, leadless pacemakers. The new pacemakers offer 40% more battery life, projecting a battery life of nearly 16 and 17 years, respectively. Additionally, they are the world's smallest pacemakers and the only leadless pacemakers with remote monitoring capabilities, providing significant benefits to patients. Medtronic's legacy in cardiac pacing includes several groundbreaking innovations, positioning the company as a leader in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
News

Hypertension Control Program Aims to Tackle Major Driver of Health Disparities for Black Americans

Rhea-AI Summary
Association of Black Cardiologists (ABC) announced the launch of its Hypertension Control Program, offering 50 member clinicians the opportunity to receive American Hypertension Specialist Certification. The program aims to improve cardiovascular health outcomes for Black patients, who are disproportionately impacted by hypertension. Medtronic is sponsoring the program and providing support for clinicians to receive certification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
News

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Rhea-AI Summary
Medtronic plc (NYSE:MDT) to participate in the 42nd annual J.P. Morgan healthcare conference. Geoff Martha, Chairman and CEO, will make a formal presentation and answer questions on January 8, 2024. A live webcast of the presentation and Q&A session will be available on the company's investor relations webpage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences
-
News

Medtronic Continues To Rank in the DJSI World Index for 2023

Rhea-AI Summary
Medtronic plc (MDT) continues to be included in the Dow Jones Sustainability World Index (DJSI) as one of the world's leading companies for sustainability, based on their strong environmental, social, and governance (ESG) management and performance. The company's FY2023 Sustainability Report highlights progress on ESG targets, including revenue from new products, patient access, inclusion, diversity, equity, responsible supply management, climate risk and resilience, and patient safety and product quality.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
none
News

Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation

Rhea-AI Summary
Medtronic plc (NYSE: MDT) has received FDA approval for the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation. The system is the first of its kind to receive FDA approval and boasts excellent safety, efficacy, and efficiency. The PulseSelect PFA system is designed to provide rapid, effective pulmonary vein isolation (PVI) and is supported by the PULSED AF study, showing a 0.7% safety event rate and clinical success rates of 80% in both paroxysmal and persistent AF patients. The system also includes differentiated safety features, built-in safety measures, and a small, maneuverable catheter, making it a significant advancement in AF ablation technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
fda approval

FAQ

What is the current stock price of Medtronic plc (MDT)?

The current stock price of Medtronic plc (MDT) is $86.21 as of November 22, 2024.

What is the market cap of Medtronic plc (MDT)?

The market cap of Medtronic plc (MDT) is approximately 109.1B.

What does Medtronic plc specialize in?

Medtronic specializes in developing and manufacturing therapeutic medical devices for chronic diseases, including pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools.

Where are Medtronic’s headquarters located?

Medtronic’s operational and executive headquarters are in Minneapolis, Minnesota, while its legal headquarters are in Dublin, Ireland, following its acquisition of Covidien in 2015.

How significant are Medtronic’s international sales?

International sales account for roughly 50% of Medtronic’s total revenue.

What recent advancements has Medtronic made in AI for healthcare?

Medtronic recently launched the ColonPRO™ software for the GI Genius™ intelligent endoscopy system, enhancing AI-driven polyp detection and procedural highlights. The company also partnered with Modernizing Medicine® to integrate AI data with EHR systems.

What are Medtronic’s recent financial achievements?

Medtronic reported a global revenue of $32.364 billion for fiscal year 2024, a 3.6% increase from the previous year, driven by growth in its Cardiovascular, Neuroscience, Medical Surgical, and Diabetes portfolios.

What new technology has Medtronic introduced for chronic pain treatment?

Medtronic introduced the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS), which the U.S. FDA approved for the treatment of chronic pain.

How many employees does Medtronic have worldwide?

Medtronic has a global team of over 95,000 employees across 150 countries.

What is Medtronic’s mission?

Medtronic's mission is to alleviate pain, restore health, and extend life.

Where can I find more information about Medtronic?

For more information about Medtronic, visit their official website at Medtronic.com.

How does Medtronic approach innovation in healthcare?

Medtronic leverages its diverse knowledge, insatiable curiosity, and commitment to helping those in need to deliver innovative technologies that transform lives, focusing on engineering extraordinary healthcare solutions.

Stock MDT logo
Medtronic plc

NYSE:MDT

MDT Rankings

#117 Ranked by Market Cap
#928 Ranked by Dividends

MDT Stock Data

109.06B
1.28B
0.26%
85.42%
0.79%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GALWAY